• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺样囊性癌异种移植模型系统的建立与鉴定。

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

机构信息

Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA.

出版信息

Lab Invest. 2011 Oct;91(10):1480-90. doi: 10.1038/labinvest.2011.105. Epub 2011 Jun 27.

DOI:10.1038/labinvest.2011.105
PMID:21709671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4151120/
Abstract

Adenoid cystic carcinoma (ACC) is one of the most common malignancies to arise in human salivary glands, and it also arises in the glandular tissue of other organ systems. To address the paucity of experimental model systems for this tumor type, we have undertaken a program of transplanting tissue samples of human ACC into immunodeficient nu/nu mice to create xenograft model systems. In 17 of 23 attempts (74%), xenograft tumors were successfully grown. In all cases, the histologic appearance of the donating tumor was recapitulated in the subsequent xenograft. Characterization of a subset of xenograft models by immunohistochemical biomarkers and by RNA transcript microarray analysis showed good fidelity in the recapitulation of gene expression patterns in the xenograft tumors compared with the human donor tumors. As ACC is known to frequently contain a t(6;9) translocation that fuses the MYB and NFIB genes, fluorescence in situ hybridization (FISH) of 12 ACC xenograft models was performed that assayed MYB locus break-apart and MYB-NFIB locus fusion. Of 12 xenograft models, 11 (92%) revealed MYB locus rearrangement and 10 (83%) showed evidence of fusion of the MYB and NFIB loci. The two related xenograft models (derived from primary and metastatic tumors, respectively, of the same human subject) were karyotyped, showing a t(1;6) translocation, suggesting MYB translocation to a novel fusion partner gene. Overall, our results indicate that ACC is amenable to xenografting and that ACC xenograft models recapitulate the molecular and morphologic characteristics of human tumors, suggesting utility as valid experimental and preclinical model systems for this disease.

摘要

腺样囊性癌 (ACC) 是人类唾液腺中最常见的恶性肿瘤之一,也发生在其他器官系统的腺体组织中。为了解决这种肿瘤类型缺乏实验模型系统的问题,我们着手将人 ACC 的组织样本移植到免疫缺陷的 nu/nu 小鼠中,以创建异种移植模型系统。在 23 次尝试中的 17 次(74%),成功地生长了异种移植肿瘤。在所有情况下,供体肿瘤的组织学外观都在随后的异种移植中得到了重现。通过免疫组织化学生物标志物和 RNA 转录微阵列分析对一部分异种移植模型进行了表征,结果表明在异种移植肿瘤中重现基因表达模式的保真度很好,与人类供体肿瘤相比。由于已知 ACC 经常包含融合 MYB 和 NFIB 基因的 t(6;9)易位,因此对 12 种 ACC 异种移植模型进行了荧光原位杂交 (FISH) 检测,以检测 MYB 基因座断裂和 MYB-NFIB 基因座融合。在 12 种异种移植模型中,有 11 种(92%)显示 MYB 基因座重排,有 10 种(83%)显示 MYB 和 NFIB 基因座融合的证据。两个相关的异种移植模型(分别来自同一人类患者的原发性和转移性肿瘤)进行了染色体核型分析,显示 t(1;6)易位,提示 MYB 易位到一个新的融合伙伴基因。总的来说,我们的结果表明 ACC 适合异种移植,并且 ACC 异种移植模型重现了人类肿瘤的分子和形态特征,表明它们可用作该疾病的有效实验和临床前模型系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/c9610e237f79/nihms-560283-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/9ade2e10c6d4/nihms-560283-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/b03c473d084a/nihms-560283-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/2f44ea0232f1/nihms-560283-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/fc2071a9e481/nihms-560283-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/c9610e237f79/nihms-560283-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/9ade2e10c6d4/nihms-560283-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/b03c473d084a/nihms-560283-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/2f44ea0232f1/nihms-560283-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/fc2071a9e481/nihms-560283-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98d/4151120/c9610e237f79/nihms-560283-f0005.jpg

相似文献

1
Development and characterization of xenograft model systems for adenoid cystic carcinoma.腺样囊性癌异种移植模型系统的建立与鉴定。
Lab Invest. 2011 Oct;91(10):1480-90. doi: 10.1038/labinvest.2011.105. Epub 2011 Jun 27.
2
MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study.采用 NanoString 分析鉴定存档腺样囊性癌组织中的 MYB-NFIB 基因融合:一项探索性研究。
Diagn Pathol. 2019 Jul 13;14(1):78. doi: 10.1186/s13000-019-0855-8.
3
Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.全面分析唾液腺腺样囊性癌中的 MYB-NFIB 基因融合:发生率、变异性及临床病理意义。
Clin Cancer Res. 2010 Oct 1;16(19):4722-31. doi: 10.1158/1078-0432.CCR-10-0463. Epub 2010 Aug 11.
4
Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.在缺乏t(6;9)易位的涎腺腺样囊性癌中具有复发性MYBL1-NFIB融合的新型MYBL1基因重排
Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.
5
[Correlation of MYB/NFIB gene fusion with the grade and prognosis of head and neck adenoid cystic carcinoma and the concordance of two detection methods].[MYB/NFIB基因融合与头颈部腺样囊性癌分级及预后的相关性及两种检测方法的一致性]
Zhonghua Bing Li Xue Za Zhi. 2024 Feb 8;53(2):149-154. doi: 10.3760/cma.j.cn112151-20230914-00172.
6
Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts.皮肤腺样囊性癌的一小部分与MYBL1基因改变有关,类似于其皮肤外对应物。
Am J Dermatopathol. 2018 Oct;40(10):721-726. doi: 10.1097/DAD.0000000000001091.
7
Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.1p36 基因座缺失在唾液腺腺样囊性癌中的预后意义。
Virchows Arch. 2018 Oct;473(4):471-480. doi: 10.1007/s00428-018-2349-6. Epub 2018 Apr 4.
8
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.头颈部腺样囊性癌中的MYB重排及临床病理特征
Laryngoscope. 2015 Sep;125(9):E292-9. doi: 10.1002/lary.25356. Epub 2015 May 11.
9
Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.分析 MYB 表达和 MYB-NFIB 基因融合在腺样囊性癌和其他唾液腺肿瘤中的作用。
Mod Pathol. 2011 Sep;24(9):1169-76. doi: 10.1038/modpathol.2011.86. Epub 2011 May 13.
10
MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions.MYB-NFIB 融合转录本在腺样囊性癌中的研究现状与未来方向。
Crit Rev Oncol Hematol. 2022 Aug;176:103745. doi: 10.1016/j.critrevonc.2022.103745. Epub 2022 Jun 20.

引用本文的文献

1
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression.交感神经轴突发生促进腺样囊性癌进展。
J Exp Med. 2025 Jul 7;222(7). doi: 10.1084/jem.20242250. Epub 2025 Apr 24.
2
Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancer.全表观基因组分析揭示前列腺癌辐射诱导毒性风险的潜在生物标志物。
Clin Epigenetics. 2025 Mar 6;17(1):43. doi: 10.1186/s13148-025-01846-8.
3
Establishment and characterization of cMYB-expressing human salivary adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and matching patient-derived xenograft model (UM-PDX-HACC-14).

本文引用的文献

1
MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.MYB 表达与易位在腺样囊性癌和其他具有临床病理相关性的唾液腺肿瘤中的研究。
Am J Surg Pathol. 2011 Jan;35(1):92-9. doi: 10.1097/PAS.0b013e3182002777.
2
Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.美国乳腺腺样囊性癌(1977 年至 2006 年):一项基于人群的队列研究。
Breast Cancer Res. 2010;12(4):R54. doi: 10.1186/bcr2613. Epub 2010 Jul 23.
3
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.
建立并鉴定表达 cMYB 的人涎腺腺样囊性癌细胞系(UM-HACC-14、UM-HACC-6)及其相应的患者来源异种移植模型(UM-PDX-HACC-14)。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Oct;138(4):516-531. doi: 10.1016/j.oooo.2024.06.005. Epub 2024 Jun 11.
4
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.腺泡状横纹肌肉瘤的空间免疫分析显示 B7-H4 是侵袭性肿瘤的治疗靶点。
Clin Cancer Res. 2023 Aug 15;29(16):3162-3171. doi: 10.1158/1078-0432.CCR-23-0514.
5
Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma.维甲酸受体/视黄酸 X 受体信号转导的反向激动剂作为针对人腺样囊性癌的谱系特异性抗肿瘤药物。
J Natl Cancer Inst. 2023 Jul 6;115(7):838-852. doi: 10.1093/jnci/djad062.
6
Using PDX animal models to identify and stratify adenoid cystic carcinoma patients presenting an enhanced response to HDAC inhibitors.利用人源肿瘤异种移植(PDX)动物模型来识别和分层对组蛋白去乙酰化酶(HDAC)抑制剂反应增强的腺样囊性癌患者。
Am J Cancer Res. 2023 Jan 15;13(1):143-160. eCollection 2023.
7
as a toolkit to tackle cancer and its metabolism.作为一种应对癌症及其新陈代谢的工具。
Front Oncol. 2022 Aug 25;12:982751. doi: 10.3389/fonc.2022.982751. eCollection 2022.
8
Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.腺样囊性癌中MYB-NFIB融合表达的发展与特征
Cancers (Basel). 2022 Apr 30;14(9):2263. doi: 10.3390/cancers14092263.
9
A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma.腺样囊性癌分子治疗靶点的当代综述
Cancers (Basel). 2022 Feb 16;14(4):992. doi: 10.3390/cancers14040992.
10
Systemic therapies for salivary gland adenoid cystic carcinoma.涎腺腺样囊性癌的全身治疗
Am J Cancer Res. 2021 Sep 15;11(9):4092-4110. eCollection 2021.
患者来源的非小细胞肺癌第一代异种移植物:预测个体化化疗药物反应的有前途的工具。
Clin Cancer Res. 2010 Mar 1;16(5):1442-51. doi: 10.1158/1078-0432.CCR-09-2878. Epub 2010 Feb 23.
4
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.MYB和NFIB转录因子基因在乳腺癌和头颈癌中反复融合。
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18740-4. doi: 10.1073/pnas.0909114106. Epub 2009 Oct 19.
5
Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2.基因分析揭示了6种腺样囊性癌细胞系(ACC2、ACC3、ACCM、ACCNS、ACCS和CAC2)存在交叉污染和错误识别的情况。
PLoS One. 2009 Jun 25;4(6):e6040. doi: 10.1371/journal.pone.0006040.
6
Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.新斯科舍省腺样囊性癌的发病率:一项基于30年人群的流行病学研究。
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):642-8.
7
p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma.p63免疫组化在鉴别腺样囊性癌与基底样鳞状细胞癌中的应用
Mod Pathol. 2005 May;18(5):645-50. doi: 10.1038/modpathol.3800329.
8
Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.涎腺肿瘤腺样囊性癌、多形性低度腺癌以及基底细胞腺瘤和小管状腺瘤中p63表达的评估。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 May;97(5):613-9. doi: 10.1016/S1079210403005742.
9
Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.《鼠与人:无胸腺裸鼠模型在抗癌药物研发中的价值与局限》
Eur J Cancer. 2004 Apr;40(6):827-36. doi: 10.1016/j.ejca.2003.11.028.
10
Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.早期传代异种移植结肠癌中抗癌药物反应及分子标志物表达
Eur J Cancer. 2004 Jan;40(2):298-307. doi: 10.1016/j.ejca.2003.10.011.